IONIS PHARMACEUTICALS INC IONS
IONIS PHARMACEUTICALS INC statistics & valuation
Market cap$13.4B
P / S14.2×
P / B27.4×
Net margin-40.4%
Return on equity-78.0%
FCF margin-33.9%
Net debt$1.4B
Enterprise value USD$14.9B
Earnings yield EBIT/EV-2.6%
Return on capital-13.9%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -40.4% | -67.4% | -44.9% | -69.8% | -3.7% | -23.6% | 32.6% | -10.2% | 6.0% | -5.4% |
| Net margin | -40.4% | -64.4% | -46.5% | -45.9% | -3.5% | -60.9% | 24.8% | 45.6% | 0.1% | -16.2% |
| FCF margin | -33.9% | -77.5% | -42.1% | -49.4% | 2.3% | 0.1% | 28.0% | 98.3% | 27.1% | -32.0% |
| Return on assets | -10.8% | -15.1% | -12.3% | -10.6% | -1.1% | -18.6% | 8.6% | 10.3% | 0.0% | -6.6% |
| Return on equity | -78.0% | -77.1% | -94.7% | -47.1% | -3.7% | -59.8% | 17.6% | 24.9% | 0.1% | -60.7% |
| Debt / equity | 3.71× | 2.13× | 3.38× | 2.08× | — | — | — | — | — | — |
| Current ratio | 3.83 | 8.47 | 5.90 | 7.07 | 9.75 | 3.56 | 9.97 | 7.88 | 4.80 | 5.96 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.